As delineated in Table 1, individuals with hepatobiliary cancer demonstrated significantly higher agrin concentrations, averaging 7.97 ng/mL compared to 4.27 ng/mL observed in controls without a cancer history (Figure 1, p < 0.001). This evidence concerns the gene AGRN and cancer.